Philadelphia-Negative Chronic Myeloid LeukemiaSymptoms, Doctors, Treatments, Advances & More
Philadelphia-Negative Chronic Myeloid Leukemia Overview
Learn About Philadelphia-Negative Chronic Myeloid Leukemia
View Main Condition: Leukemia
UT MD Anderson Cancer Center
Tapan Kadia is a Hematologist practicing medicine in Cary, North Carolina. Dr. Kadia is rated as an Elite provider by MediFind in the treatment of Philadelphia-Negative Chronic Myeloid Leukemia. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
Office
Hagop Kantarjian is an Oncologist practicing medicine in Houston, Texas. Dr. Kantarjian is rated as an Elite provider by MediFind in the treatment of Philadelphia-Negative Chronic Myeloid Leukemia. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Aspiration, and Splenectomy.
City Of Hope Comprehensive Cancer Center-Duarte
Stephen Forman is a Hematologist and an Oncologist practicing medicine in Duarte, California. Dr. Forman is rated as a Distinguished provider by MediFind in the treatment of Philadelphia-Negative Chronic Myeloid Leukemia. He is also highly rated in 55 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.
Summary: RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.
Summary: RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center
